Acurx Pharmaceuticals, Inc. (ACXP)

NASDAQ: ACXP · IEX Real-Time Price · USD

2.130

+0.330 (18.33%)

At close: Apr 18, 2024, 4:00 PM

2.270

+0.140 (6.57%)

After-hours: Apr 18, 2024, 7:40 PM EDT

Acurx Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	8.53	7.34	10.78	2.4	2.42
Research & Development	6.04	4.75	2.03	2.2	3.51
Operating Expenses	14.58	12.09	12.81	4.6	5.93
Operating Income	-14.58	-12.09	-12.81	-4.6	-5.93
Other Expense / Income	-	-	-0.07	-	-
Pretax Income	-14.58	-12.09	-12.75	-4.6	-5.93
Net Income	-14.58	-12.09	-12.75	-4.6	-5.93
Shares Outstanding (Basic)	13	11	9	6	-
Shares Outstanding (Diluted)	13	11	9	6	-
Shares Change	17.15%	26.72%	37.88%	-	-
EPS (Basic)	-1.15	-1.12	-1.49	-0.74	-
EPS (Diluted)	-1.15	-1.12	-1.49	-0.74	-
Free Cash Flow	-9.8	-7.54	-5.01	-3.35	-3.99
Free Cash Flow Per Share	-0.77	-0.70	-0.59	-0.54	-
EBITDA	-14.58	-12.09	-12.75	-4.6	-5.93
EBIT	-14.58	-12.09	-12.75	-4.6	-5.93

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).